1. Home
  2. CVLT vs BLCO Comparison

CVLT vs BLCO Comparison

Compare CVLT & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commvault Systems Inc.

CVLT

Commvault Systems Inc.

HOLD

Current Price

$121.72

Market Cap

6.1B

Sector

Technology

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.99

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVLT
BLCO
Founded
1996
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Ophthalmic Goods
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
6.0B
IPO Year
2006
2022

Fundamental Metrics

Financial Performance
Metric
CVLT
BLCO
Price
$121.72
$16.99
Analyst Decision
Buy
Hold
Analyst Count
13
14
Target Price
$193.83
$17.31
AVG Volume (30 Days)
647.6K
399.7K
Earning Date
01-27-2026
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.76
N/A
Revenue
$1,095,835,000.00
$4,976,000,000.00
Revenue This Year
$19.22
$8.08
Revenue Next Year
$12.47
$5.77
P/E Ratio
$69.10
N/A
Revenue Growth
22.02
6.23
52 Week Low
$114.47
$10.45
52 Week High
$200.69
$18.99

Technical Indicators

Market Signals
Indicator
CVLT
BLCO
Relative Strength Index (RSI) 36.98 60.98
Support Level $119.27 $16.39
Resistance Level $125.65 $17.41
Average True Range (ATR) 3.67 0.46
MACD 1.71 0.06
Stochastic Oscillator 64.86 72.71

Price Performance

Historical Comparison
CVLT
BLCO

About CVLT Commvault Systems Inc.

CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Cleanroom Recovery, HyperScale X, Air Gap Protect, Compliance, Cloud Rewind, and Clumio Backtrack. The company operates in the United States and exports to many other countries.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: